These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 22483286

  • 1. Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.
    Srinivasan V, Zakaria R, Othaman Z, Brzezinski A, Prasad A, Brown GM.
    CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):180-9. PubMed ID: 22483286
    [Abstract] [Full Text] [Related]

  • 2. Melatonergic drugs in clinical practice.
    Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Cardinali DP.
    Arzneimittelforschung; 2008 Mar; 58(1):1-10. PubMed ID: 18368944
    [Abstract] [Full Text] [Related]

  • 3. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?
    Srinivasan V, Brzezinski A, Pandi-Perumal SR, Spence DW, Cardinali DP, Brown GM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun 01; 35(4):913-23. PubMed ID: 21453740
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic potential of melatonin agonists.
    Cardinali DP, Pandi-Perumal SR, Srinivasan V, Spence DW, Trakht I.
    Expert Rev Endocrinol Metab; 2008 Mar 01; 3(2):269-279. PubMed ID: 30764095
    [Abstract] [Full Text] [Related]

  • 5. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.
    Int J Neurosci; 2009 Mar 01; 119(6):821-46. PubMed ID: 19326288
    [Abstract] [Full Text] [Related]

  • 6. Melatonin and melatonergic drugs in sleep disorders.
    Kim HK, Yang KI.
    Transl Clin Pharmacol; 2022 Dec 01; 30(4):163-171. PubMed ID: 36632077
    [Abstract] [Full Text] [Related]

  • 7. The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives.
    Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.
    World J Biol Psychiatry; 2009 Dec 01; 10(4 Pt 2):342-54. PubMed ID: 18609422
    [Abstract] [Full Text] [Related]

  • 8. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
    Zlotos DP, Jockers R, Cecon E, Rivara S, Witt-Enderby PA.
    J Med Chem; 2014 Apr 24; 57(8):3161-85. PubMed ID: 24228714
    [Abstract] [Full Text] [Related]

  • 9. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J, Cohen DA, Sharpley AL.
    Cochrane Database Syst Rev; 2014 Mar 21; (3):CD009178. PubMed ID: 24659320
    [Abstract] [Full Text] [Related]

  • 10. Ramelteon: profile of a new sleep-promoting medication.
    Owen RT.
    Drugs Today (Barc); 2006 Apr 21; 42(4):255-63. PubMed ID: 16703122
    [Abstract] [Full Text] [Related]

  • 11. Searching for new options for treating insomnia: are melatonin and ramelteon beneficial?
    Bellon A.
    J Psychiatr Pract; 2006 Jul 21; 12(4):229-43. PubMed ID: 16883148
    [Abstract] [Full Text] [Related]

  • 12. [Delirium, insomnia in hospitalization and ramelteon].
    Ito T.
    Nihon Rinsho; 2012 May 21; 70(5):907-13. PubMed ID: 22620020
    [Abstract] [Full Text] [Related]

  • 13. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
    Pandi-Perumal SR, Srinivasan V, Poeggeler B, Hardeland R, Cardinali DP.
    Nat Clin Pract Neurol; 2007 Apr 21; 3(4):221-8. PubMed ID: 17410109
    [Abstract] [Full Text] [Related]

  • 14. Melatonin and its analogs in insomnia and depression.
    Cardinali DP, Srinivasan V, Brzezinski A, Brown GM.
    J Pineal Res; 2012 May 21; 52(4):365-75. PubMed ID: 21951153
    [Abstract] [Full Text] [Related]

  • 15. Ramelteon: a review of its therapeutic potential in sleep disorders.
    Pandi-Perumal SR, Srinivasan V, Spence DW, Moscovitch A, Hardeland R, Brown GM, Cardinali DP.
    Adv Ther; 2009 Jun 21; 26(6):613-26. PubMed ID: 19568703
    [Abstract] [Full Text] [Related]

  • 16. Ramelteon: a melatonin receptor agonist for the treatment of insomnia.
    Devi V, Shankar PK.
    J Postgrad Med; 2008 Jun 21; 54(1):45-8. PubMed ID: 18296808
    [Abstract] [Full Text] [Related]

  • 17. Ramelteon: new drug. Insomnia: no role for risky placebos.
    Prescrire Int; 2008 Oct 21; 17(97):183-6. PubMed ID: 19534018
    [Abstract] [Full Text] [Related]

  • 18. Ramelteon for the treatment of insomnia.
    Borja NL, Daniel KL.
    Clin Ther; 2006 Oct 21; 28(10):1540-55. PubMed ID: 17157111
    [Abstract] [Full Text] [Related]

  • 19. Ramelteon.
    McGechan A, Wellington K.
    CNS Drugs; 2005 Oct 21; 19(12):1057-65; discussion 1066-7. PubMed ID: 16332146
    [Abstract] [Full Text] [Related]

  • 20. Insomnia in Elderly Patients: Recommendations for Pharmacological Management.
    Abad VC, Guilleminault C.
    Drugs Aging; 2018 Sep 21; 35(9):791-817. PubMed ID: 30058034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.